Lv4
520 积分 2025-02-27 加入
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
1个月前
已完结
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
1个月前
已完结
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
1个月前
已关闭
Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes: A Phase 2b Randomized Clinical Trial
1个月前
已关闭
Safety, tolerability, relative bioavailability, pharmacokinetics, and pharmacodynamics of single and multiple doses of the novel oral bofanglutide in healthy Chinese participants
1个月前
已完结
Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
2个月前
已完结
Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial
2个月前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, doubleblind, placebo-controlled, phase 3 tr
2个月前
已完结
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide
3个月前
已完结
Digitial memory test for detecting and assessing cognitive impairment in parkinson's disease
1年前
已驳回
The Influence of Gen‐AI Assisted Learning on Primary School Students' Math Anxiety: An Intervention Study
1年前
已采纳
Rapid Charge Extraction via Hole and Electron Transfer Layers on Cu2O Photocathode for Stable and Efficient Photoelectrochemical Water Reduction
1年前
已采纳
皖公网安备34019202002308
